Denali Therapeutics Inc. DNLI
18.45 USD +0.25 (+1.37%)
Regular-session close
18.45 0.00 0.00%
After hours · Nov 20, 4:52 PM ET
17.92 Day range 18.85
16.02 52-week range 27.21
- YTD
- +11.75%
- 1 year
- +7.52%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 555.34M | 487.34M | 527.23M | 449.21M | 344.41M | |
| 418.78M | 396.44M | 423.88M | 358.73M | 265.35M | |
| 136.56M | 105.44M | 103.35M | 90.47M | 79.06M | |
| -555.34M | -487.34M | -196.70M | -340.74M | -295.75M | |
| 102.00K | 68.00K | 30.00K | 21.00K | -575.00K | |
| -512.54M | -422.77M | -145.22M | -325.99M | -290.58M | |
| -512.54M | -422.77M | -145.22M | -325.99M | -290.58M | |
| -512.54M | -422.77M | -145.22M | -325.99M | -290.58M | |
| -512.54M | -422.77M | -145.22M | -325.99M | -290.58M | |
| -2.97 | -2.57 | -1.06 | -2.60 | -2.39 | |
| -2.97 | -2.57 | -1.06 | -2.60 | -2.39 | |
| -2.97 | -2.57 | -1.06 | -2.60 | -2.39 | |
| -512.44M | -422.70M | -145.19M | -325.97M | -291.16M | |
| -512.44M | -422.70M | -145.19M | -325.97M | -291.16M | |
| 172.65M | 164.47M | 137.37M | 125.53M | 121.52M | |
| 172.65M | 164.47M | 137.37M | 125.53M | 121.52M |
